UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, cilt.16, sa.3, ss.77-80, 2017 (ESCI)
Objective: Prostate cancer (PCa) is the second most commonly seen cancer type worldwide. Mortality due to PCa is mostly linked to the development of castration resistant PCa (CRPC). In these patients, the main treatment option is docetaxel based chemotherapy (DBC). In this study, we aimed to present our retrospective series.